Search Results - Bizec, Jean‐Louis
- Showing 1 - 4 results of 4
-
1
Brief Report on the Efficacy of Nivolumab in Patients With Previously Treated Advanced Large-Cell Neuroendocrine Cancer of the Lung by Agar, Camille, Geier, Margaux, Léveiller, Guillaume, Lamy, Régine, Bizec, Jean-Louis, Tiercin, Marie, Bernier, Cyril, Robinet, Gilles, Léna, Hervé, Ricordel, Charles, Corre, Romain
Published 2020Text -
2
High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU by Guy, Tiphaine, Créac'hcadec, Audrey, Ricordel, Charles, Salé, Alexandre, Arnouat, Baptiste, Bizec, Jean-Louis, Langelot, Marie, Lineau, Christine, Marquette, David, Martin, Françoise, Lederlin, Mathieu, Jouneau, Stéphane
Published 2020Text -
3
Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer by Geier, Margaux, Descourt, Renaud, Corre, Romain, Léveiller, Guillaume, Lamy, Régine, Goarant, Éric, Bizec, Jean‐Louis, Bernier, Cyril, Quéré, Gilles, Amrane, Karim, Gaye, Elisabeth, Lucia, François, Burte, Emilie, Chouaid, Christos, Robinet, Gilles
Published 2020Text -
4
First‐line pembrolizumab for non–small cell lung cancer patients with PD‐L1 ≥50% in a multicenter real‐life cohort: The PEMBREIZH study by Amrane, Karim, Geier, Margaux, Corre, Romain, Léna, Hervé, Léveiller, Guillaume, Gadby, Florence, Lamy, Régine, Bizec, Jean‐Louis, Goarant, Eric, Robinet, Gilles, Gouva, Sylvie, Quere, Gilles, Abgral, Ronan, Schick, Ulrike, Bernier, Cyril, Chouaid, Christos, Descourt, Renaud
Published 2020Text